Reducing VP Shunt Infection Risk

Preoperative Antibiotic Prophylaxis

• The American Academy of Neurosurgery recommends administering systemic intravenous antibiotics before shunt surgery to reduce infection risk from 10.7% to 5.9% (relative risk reduction of 45%) 1, 3, 4
• Administer antibiotics providing gram-positive coverage (first-generation cephalosporin, nafcillin, clindamycin, or vancomycin) before skin incision 5
• Meta-analysis of randomized controlled trials demonstrates a risk ratio of 0.55 (95% CI 0.38-0.81) favoring preoperative antibiotics, representing Level II evidence with moderate clinical certainty 1, 4, 6

Antibiotic-Impregnated Shunt Hardware

• The American Academy of Neurosurgery recommends using antibiotic-impregnated shunt tubing for all pediatric shunt placements as it provides superior infection prevention compared to standard silicone hardware 2
• A multicenter randomized controlled trial demonstrated significant reduction in postoperative shunt infection, particularly in children, with an odds ratio of 0.21 (95% CI 0.08-0.55), representing a Level I recommendation with high clinical certainty 2

High-Risk Patient Identification

• Previous shunt infection and recent shunt revision are risk factors for infection 3
• Most infections occur within the first 2 months after surgery, with 30 days being the mean time to infection 5

Surgical Technique Considerations

• Ensure meticulous sterile technique, as most infections are caused by skin flora (coagulase-negative Staphylococcus, S. epidermidis, S. aureus) 5

Management of Infected Shunts

• Remove infected hardware completely when possible, as supplementation with partial or complete shunt removal is recommended for managing established infections 7